Ondansetron Versus Domperidone for Treating Vomiting in Acute Gastroenteritis in Children

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Vomiting in Infants and/or ChildrenAcute Gastroenteritis
Interventions
DRUG

Ondansetron

Ondansetron group received oral suspension of ondansetron as 0.15mg per body weight

Trial Locations (1)

64000

Tehsil Headquarter Hospital, Liaquatpur

All Listed Sponsors
lead

Tehsil Headquarter Hospital

OTHER_GOV

NCT05076461 - Ondansetron Versus Domperidone for Treating Vomiting in Acute Gastroenteritis in Children | Biotech Hunter | Biotech Hunter